| Mon, Feb 8, 2010 | | | Alkermes Retains Neutral Rec Zacks.com (Mon, Feb 8)
| | | [video] Alkermes CEO Sounds Off at CNBC (Mon, Feb 8)
| | Sat, Feb 6, 2010 | | | New Star Analyst Rankings for Alkermes, Inc. StarMine (Sat, Feb 6)
| | Fri, Feb 5, 2010 | | | [$$] Russell 2000 Falls for Fourth Week in a Row at The Wall Street Journal Online (Fri, Feb 5)
| | | Biotech Stocks: Drug stocks fall; Alkermes rallies on upgrade at MarketWatch (Fri, Feb 5)
| | | Biotech Stocks: Drug stocks slip; Alkermes rallies on upgrade at MarketWatch (Fri, Feb 5)
| | | Lower Q3 Loss for Alkermes Zacks.com (Fri, Feb 5)
| | | Drug stocks dip; Alkermes jumps on upgrade at MarketWatch (Fri, Feb 5)
| | | Premarket roundup: PerkinElmer, NCR AP (Fri, Feb 5)
| | | Ahead of the Bell: Alkermes upgraded on 3Q results AP (Fri, Feb 5)
| | | Wall Street Breakfast: Must-Know News at Seeking Alpha (Fri, Feb 5)
| | | Alkermes upgraded by Jefferies & Co Briefing.com (Fri, Feb 5)
| | Thu, Feb 4, 2010 | | | Alkermes, Inc. F3Q10 (Qtr End 12/31/09) Earnings Call Transcript at Seeking Alpha (Thu, Feb 4)
| | | Alkermes reports 3Q loss, smaller than expected AP (Thu, Feb 4)
| | | UPDATE - Alkermes posts narrower-than-expected Q3 loss at Reuters (Thu, Feb 4)
| | | ALKERMES INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Thu, Feb 4)
| | | Alkermes Reports Third Quarter Fiscal 2010 Financial Results Business Wire (Thu, Feb 4)
| | | Alkermes Testing its Version of Popular Schizophrenia Drug at TheStreet.com (Thu, Feb 4)
| | | Alkermes Testing Schizophrenia Drug at TheStreet.com (Thu, Feb 4)
| | | Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders Business Wire (Thu, Feb 4)
| Add ALKS News to My Yahoo!:

| |
|